A nationwide analysis on the influence of obesity in inflammatory bowel disease hospitalizations
| Autor: | Dhanshree Solanki, Hafeez Shaka, Farah Wani, Asim Kichloo, Jagmeet P. Singh, Dushyant Singh Dahiya |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
medicine.medical_specialty
business.industry Gastroenterology Secondary diagnosis Disease medicine.disease Hospital charge Obesity Inflammatory bowel disease Middle age 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Internal medicine Epidemiology Cohort medicine 030211 gastroenterology & hepatology business |
| Zdroj: | Intestinal Research. 20:342-349 |
| ISSN: | 2288-1956 1598-9100 |
| Popis: | Background/Aims: Proinflammatory cytokines released from adipocytes can influence the development, progression, and treatment of inflammatory bowel disease (IBD), and may be associated with worse clinical outcomes. Methods: For 2016–2018, we analyzed data from the Nationwide Inpatient Sample to identify adult (≥18 years) hospitalizations with a primary discharge diagnosis of IBD. The study sample was divided based on the presence or absence of obesity. The primary outcomes included inpatient mortality, while the secondary outcomes consisted of system-based complications and disease implications on the United States healthcare system.Results: We identified 282,005 hospitalizations of IBD from 2016 to 2018. Of these hospitalizations, 26,465 (9.4%) had a secondary diagnosis of obesity while 255,540 (90.6%) served as controls. IBD hospitalizations with obesity had a higher mean age (47.9 years vs. 45.2 years, PPPPP |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|